Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity
E1A binding protein p300 (EP300) is mutated in diverse cancers. Nevertheless, a systematic investigation into the associations of EP300 mutations with genome instability and antitumor immunity in pan-cancer remains lacking. Using the datasets from The Cancer Genome Atlas, we analyzed the correlation...
Main Authors: | Zuobing Chen, Canping Chen, Lin Li, Tianfang Zhang, Xiaosheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.729927/full |
Similar Items
-
The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer
by: Zuobing Chen, et al.
Published: (2021-01-01) -
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum
by: María López, et al.
Published: (2018-03-01) -
KALRN mutations promote antitumor immunity and immunotherapy response in cancer
by: Mengyuan Li, et al.
Published: (2020-07-01) -
The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression
by: Zhilan Zhang, et al.
Published: (2020-01-01) -
Correlate tumor mutation burden with immune signatures in human cancers
by: Xiaosheng Wang, et al.
Published: (2019-01-01)